WASHINGTON - An investigation of a U.S. military facility's mistaken shipments of live anthrax bacteria has turned up another live sample, this one from a 2008 batch sent to Australia, a U.S. defense official said on Friday.
PORTLAND, Ore. - The father of a University of Oregon student has contracted the potentially deadly meningococcal disease amid an outbreak that started in January and has killed one student, bringing the total number of people infected to seven, state health officials said on Friday.
(Reuters Health) - Obesity increases the risk for atrial fibrillation, a common heart rhythm disorder that can lead to blood clots, stroke and heart failure, a new analysis suggests.
NEW YORK - Bristol-Myers Squibb has sued a top cancer immunotherapy executive for violating confidentiality and non-compete agreements after he left for direct competitor AstraZeneca, court documents show.
(Reuters Health) - People’s estimates of how much they drink are much higher when they include weekends and holidays, according to a new survey from the UK.
SAN FRANCISCO - An Idaho law that prohibits abortions of fetuses 20 or more weeks after fertilization is unconstitutional, a U.S. appeals court ruled on Friday.
(Reuters Health) - Older women with early-stage breast cancer might be able to skip a lymph node biopsy without changing their survival odds, a small study suggests.
- A Merck & Co drug that helps the immune system fight cancer was about twice as effective as the current standard therapy for patients with recurrent or advanced head and neck cancers, according to study data released on Friday.
CHICAGO - The U.S. Department of Agriculture said Friday it is seeking to hire more federal contractors to help with the government's response to the domestic bird flu outbreak, which has resulted in more than 43 million birds being culled so far.
CHICAGO - Patients with colon and other cancers who have a specific defect in genes needed for DNA repair are far more likely to respond to a new class of drugs such as Merck & Co's Keytruda, which enlist the immune system to attack tumors, a new study has shown.